Header Logo
Last Name

Dr Maria Castro Noriega

TitleClinical Research Assistant
InstitutionCentro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM)
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My research interests are oriented towards understanding the determinants of treatment response, and diagnostic and therapeutic product development for Neglected Tropical Diseases. Since 2012 I have participated in multiple projects, ranging from translational and epidemiological research to clinical trials, all aimed to improve management of patients with Cutaneous Leishmaniasis in Colombia. Additionally, I am a GCP and GHRP trainer in the TDR supported Regional Training Center in CIDEIM (Cali, Colombia), and have responsibility for the training of clinicians in endemic areas about the diagnosis and management of cutaneous leishmaniasis, as a capacity building strategy.

    In 2017 I was granted with an EDCTP/TDR Research and Development Fellowship, to receive training in vaccine development focusing on diseases of poverty at the European Vaccine Initiative (EVI), a Product Development Partnership based in Germany.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Uribe-Restrepo AF, Prieto MD, Cossio A, Desai MM, Castro MDM. Eligibility for Local Therapies in Adolescents and Adults with Cutaneous Leishmaniasis from Southwestern Colombia: A Cross-Sectional Study. Am J Trop Med Hyg. 2019 02; 100(2):306-310. PMID: 30628567.
      View in: PubMed
    2. Uribe-Restrepo A, Cossio A, Desai MM, Dávalos D, Castro MDM. Interventions to treat cutaneous leishmaniasis in children: A systematic review. PLoS Negl Trop Dis. 2018 12; 12(12):e0006986. PMID: 30550538.
      View in: PubMed
    3. Kip AE, Castro MDM, Gomez MA, Cossio A, Schellens JHM, Beijnen JH, Saravia NG, Dorlo TPC. Simultaneous population pharmacokinetic modelling of plasma and intracellular PBMC miltefosine concentrations in New World cutaneous leishmaniasis and exploration of exposure-response relationships. J Antimicrob Chemother. 2018 08 01; 73(8):2104-2111. PMID: 29757380.
      View in: PubMed
    4. Erber AC, Arana B, Bennis I, Ben Salah A, Boukthir A, Castro Noriega MDM, Cissé M, Cota GF, Handjani F, Kebede MG, Lang T, López Carvajal L, Marsh K, Martinez Medina D, Plugge E, Olliaro P. An international qualitative study exploring patients' experiences of cutaneous leishmaniasis: study set-up and protocol. BMJ Open. 2018 06 15; 8(6):e021372. PMID: 29909372.
      View in: PubMed
    5. Berger BA, Cossio A, Saravia NG, Castro MDM, Prada S, Bartlett AH, Pho MT. Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis. PLoS Negl Trop Dis. 2017 04; 11(4):e0005459. PMID: 28384261.
      View in: PubMed
    6. Castro MDM, Cossio A, Velasco C, Osorio L. Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study. PLoS Negl Trop Dis. 2017 04; 11(4):e0005515. PMID: 28379954.
      View in: PubMed
    7. Castro MD, Gomez MA, Kip AE, Cossio A, Ortiz E, Navas A, Dorlo TP, Saravia NG. Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis. Antimicrob Agents Chemother. 2017 03; 61(3). PMID: 27956421.
      View in: PubMed
    8. Kip AE, Rosing H, Hillebrand MJ, Castro MM, Gomez MA, Schellens JH, Beijnen JH, Dorlo TP. Quantification of miltefosine in peripheral blood mononuclear cells by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Aug 15; 998-999:57-62. PMID: 26160472.
      View in: PubMed
    9. Obonaga R, Fernández OL, Valderrama L, Rubiano LC, Castro Mdel M, Barrera MC, Gomez MA, Gore Saravia N. Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species. Antimicrob Agents Chemother. 2014; 58(1):144-52. PMID: 24145529.
      View in: PubMed
    Castro Noriega's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Physical Neighbors Expand Description